Crown Bioscience, a global contract research organisation and part of JSR Life Sciences, has announced that its San Diego laboratory has achieved accreditation from the College of American Pathologists (CAP). The recognition follows the site’s Clinical Laboratory Improvement Amendments (CLIA) certification received in July 2025 and strengthens its ability to deliver clinical-grade biomarker testing for drug development programmes.
CAP accreditation is widely regarded as a benchmark for laboratory quality, confirming high standards in technical expertise, operational procedures and quality management. Along with CLIA certification, which is regulated by the U.S. Centers for Medicare & Medicaid Services, the accreditation confirms that the San Diego laboratory meets federal requirements for testing human samples and is prepared to support biomarker analysis for clinical trials.
Julie Mayer, Vice President of the Global Biomarker Platform at Crown Bioscience, said the accreditation marks an important step in expanding the company’s biomarker services. She noted that having accredited facilities in the United States will help provide dependable data for clinical studies and support partners developing new therapies.
Maria Radino, Vice President of Global Quality and Regulatory Compliance, said quality systems become increasingly important as research programmes move into clinical stages. She added that achieving both CAP and CLIA certifications reflects the company’s commitment to reliable data generation and regulatory compliance.
With these certifications, the San Diego laboratory can support biomarker testing across both preclinical and clinical research workflows. This integration allows continuity in data collection and helps ensure studies meet regulatory standards throughout development.
Crown Bioscience works with biotechnology and pharmaceutical companies on oncology and precision medicine programmes, providing research services that support drug discovery and clinical development. The company said the San Diego accreditation strengthens its global network of certified laboratories and expands its capacity to support regulated studies.
Crown Bioscience is part of JSR Life Sciences, which provides research and manufacturing solutions to the pharmaceutical and biotechnology industries. Together, the organisations focus on advancing scientific research, improving laboratory standards and helping partners bring new therapies to patients. The CAP accreditation underscores Crown Bioscience’s continued investment in quality systems and laboratory capabilities, reinforcing its role as a trusted research partner for organisations developing innovative treatments worldwide.
